Academic and Professional Credentials: MPH Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website. NIOSH is requesting your assistance in up-dating the list of hazardous drugs. Centers for Disease Control and Prevention. on Recommended by: NIOSH, Chuck Schwartz Eric Maroyka, Senior Director, Center on Pharmacy Practice Advancement sits down with Patricia C. Kienle, MPA, BCSCP, FASHP, and Michael Ganio, Senior Director, Pharmacy Practice and Quality to discuss aspects of the draft The National Institute for Occupational Safety and Health (NIOSH) List of Hazardous Drugs in Healthcare Settings 2020. 112 0 obj <> endobj If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance. School of Medicine The list was compiled from information provided by four institutions that had generated lists of hazardous drugs for their respective institutions, as well as a list from the Pharmaceutical Research and Manufacturers of America (PhRMA). to the courts under 44 U.S.C. 06/18/2020 at 8:45 am. This list includes drugs reviewed by NIOSH from January 2012 to December 2013. NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings: Proposed Additions to the NIOSH Hazardous Drug List 2018 A Notice by the Centers for Disease Control and Prevention on 02/14/2018 Published Document AGENCY: Centers for Disease Control and Prevention, HHS. Organizational Affiliation: Director, Clinical Standards and Quality Practice, Standards and Quality Division; American Society of Health-System Pharmacists Academic and Professional Credentials: MD, MPH Merck & Co., Inc. 0000052457 00000 n Z>s82jrod|`t Rj+&=wg\3gjo9swoysg GeCIV&In\,Fzp(+,p>;[ [R`b9N%:=?dn'8! %PDF-1.6 % II. Centers for Disease Control and Prevention. These tools are designed to help you understand the official document hb```u| eaX@x(gCk)La&{3L0u_r+ NIOSH is not seeking a consensus opinion from the reviewers as a group. )1kRM,e@aH:@B!4O84\:BL5eW?WG0/# H[bxqa0 Due to aggressive automated scraping of FederalRegister.gov and eCFR.gov, programmatic access to these sites is limited to access to our extensive developer APIs. %%EOF Stakeholders provided comments on each drug . &Hc$y@?T&F!. 3|({` ) 01/18/2023, 249 The NIOSH definition of hazardous drugs used in the Alert is based on a definition originally devel-oped in 1990 by the American Society of Hospital An official website of the United States government. "'H&90 Q "Y|$X LMjT@$C"k$cZ0& j CDC twenty four seven. better and aid in comparing the online edition to the print edition. on In this Issue, Documents Thank you for taking the time to confirm your preferences. Academic and Professional Credentials: Ph.D. We take your privacy seriously. Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data. 0000085361 00000 n Recommended by: NIOSH, Marty Polovich They help us to know which pages are the most and least popular and see how visitors move around the site. endstream endobj startxref First, any pharmacy that has any type of HD, as identified on the NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2016, needs to comply with USP <800>. These cookies may also be used for advertising purposes by these third parties. The National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), in the Department of Health and Human Services announces that the following draft documents are available for public comment: (1) NIOSH Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings (Procedures); (2) NIOSH List of Hazardous Drugs in Healthcare Settings, 2020 (List), including those drugs proposed for placement on the 2020 List, and (3) Managing Hazardous Drug Exposures: Information for Healthcare Settings. The documents posted on this site are XML renditions of published Federal If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance. Organizational Affiliation: Director, Toxicology and Hazard Communication Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests. Using these criteria, the NIOSH list further stratifies . %%EOF The National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC) has updated its list of hazardous drugs for 2016. the Federal Register. Organizational Affiliation: Office of the Director The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website. Federal Register provide legal notice to the public and judicial notice CDC twenty four seven. endstream endobj 3567 0 obj <. ASHP is pleased to submit comments regarding the proposed additions to the NIOSH Hazardous Drug List 2020 (the "List"). We take your privacy seriously. All information these cookies collect is aggregated and therefore anonymous. corresponding official PDF file on govinfo.gov. 0000001815 00000 n 2016-161 (September 2016) The President of the United States manages the operations of the Executive branch of Government through Executive orders. has no substantive legal effect. Federal Register. documents in the last year, by the Energy Department edition of the Federal Register. hb```| eaj90FLX!@R'[ ezhzb?BE:lG t#X#XrhaDQ;X0aACenIs|x uXi H306*g`YU` +sn Register, and does not replace the official print version or the official Proposed Additions to the NIOSH Hazardous Drug List 2018 . documents in the last year, 28 0 Information about this document as published in the Federal Register. These cookies may also be used for advertising purposes by these third parties. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page. Areas of Expertise, Discipline, or Relevant Experience: Pharmacology This notice announces the extension of the comment period until July 30, 2020. documents in the last year, 675 For complete information about, and access to, our official publications Persons with disabilities experiencing problems accessing this page should contact CDC-INFO at CDC-INFO email form: http://www.cdc.gov/info/, 800-232-4636 or the TTY number at (888) 232-6348 and ask for a 508 Accommodation PR#9342. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance. This feature is not available for this document. You can review and change the way we collect information below. documents in the last year, 274 0000027413 00000 n documents in the last year, 830 Academic and Professional Credentials: R.Ph. They help us to know which pages are the most and least popular and see how visitors move around the site. rendition of the daily Federal Register on FederalRegister.gov does not hb```C q|AdXCB>|gq]gWb-WWURuKX[a@@Taa2[CR*4(Mrl0))JA'V&=UX`GIsV3bIOP{Ff`JV-:-nf_1 b# }`p\l{Nxel\N0?(65B ECjH. 01/18/2023, 159 Academic and Professional Credentials: MN, RN, AOCN Centers for Disease Control and Prevention, HHS. OSHA/DOL The comment period for the document published on May 1, 2020 (85 FR 25439), is extended. DHHS (NIOSH) Publication No. Use the PDF linked in the document sidebar for the official electronic format. Environment, Health and Safety These cookies may also be used for advertising purposes by these third parties. The NIOSH Alert: Preventing Occupational Exposures to Antineoplastic and Other Hazardous Drugs in Health Care Settings was published in September 2004 (/niosh/docs/2004-165/). documents in the last year, 90 If you are using public inspection listings for legal research, you Toxicology, Occupational Health, Industrial Hygiene, Reviewers Selected by: NIOSH, ASHP, ONS, ANA, VA, OSHA, FDA, PhRMA, and BIO, Public Nominations Requested for Reviewers: No, Opportunities for the Public to Comment: Yes, Peer Reviewers Provided with Public Comments Before Their Review: Yes, Cynthia Reilly These markup elements allow the user to see how the document follows the You will be subject to the destination website's privacy policy when you follow the link. 4784 0 obj <>/Filter/FlateDecode/ID[<5FA92D1D04B08D49A116C786A7223D38><9416124EEFDD02439C03F97283E9A4D1>]/Index[4762 53]/Info 4761 0 R/Length 102/Prev 429892/Root 4763 0 R/Size 4815/Type/XRef/W[1 3 1]>>stream Please include the URL of the site in the Subject line of your email request that you would like to access. Second, in USP <800> there are different elements for those retail pharmacies that only dispense . Organizational Affiliation: Senior Manager, Product Stewardship Programs If emailing please type 508 Accommodation PR#9342 without quotes in the subject line of the email. documents in the last year, 973 0000086256 00000 n documents in the last year, 84 Review public comments on proposed NIOSH changes to the hazardous drug list. 0000001505 00000 n Academic and Professional Credentials: Ph.D., DABT A new format was developed for the 2014 list of hazardous drugs, as described below. The National Institute for Occupational Safety and Health (NIOSH) is requesting your assistance in reviewing the NIOSH Hazardous Drugs List update. Growing evidence highlights that acute and chronic health effects can occur due to occupational exposure to over 200 hazardous drugs used commonly in healthcare settings. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance. developer tools pages. 0000018854 00000 n Barbara MacKenzie, NIOSH, Robert A. Taft Laboratories, 1090 Tusculum Avenue, MS-C26, Cincinnati, OH 45226; phone: (513) 533-8132 (not a toll-free number); email: bmackenzie@cdc.gov. We take your privacy seriously. You can review and change the way we collect information below. 01/18/2023, 284 Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. 0000068678 00000 n documents in the last year, 876 Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data. | kR\Y| CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. [PDF 32 KB] Required Elements for Initial Public Posting Title: NIOSH Update to the Hazardous Drug List (Appendix A) Subject: NIOSH Hazardous Drug List Purpose: To provide an update of the list of hazardous drugs in the Alert: Preventing Occupational Exposures to Antineoplastic and Other Hazardous Drugs in Health Care Settings Each document posted on the site includes a link to the The National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC) has updated its list of hazardous drugs for 2016. Only official editions of the NIOSH published a notice and request for comment in the Federal Register on May 1, 2020 (85 FR 25439) regarding the development of the NIOSH List of Hazardous Drugs in Healthcare Settings and related risk management information for healthcare settings. include documents scheduled for later issues, at the request C@H documents in the last year, by the International Trade Commission NIOSH published a notice and request for comment in the Federal Register on May 1, 2020 (85 FR 25439) regarding the development of the NIOSH List of Hazardous Drugs in Healthcare Settings and related risk management information for healthcare settings. Saving Lives, Protecting People, The National Institute for Occupational Safety and Health (NIOSH), NIOSH Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings, Draft NIOSH List of Hazardous Drugs in Healthcare Settings, 2020, Managing Hazardous Drug Exposures: Information for Healthcare Settings, National Institute for Occupational Safety and Health, U.S. Department of Health & Human Services. documents in the last year, 16 These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data. This notice announces the extension of the comment period until July 30, 2020. You will be subject to the destination website's privacy policy when you follow the link. on These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. documents in the last year, 12 Answer: NIOSH hopes to return to more regular updates following finalization of the DRAFT NIOSH List of Hazardous Drugs. documents in the last year, 1487 Recommended by: Scientific or professional association, S. Leigh Verbois 0000001905 00000 n }1%o~)FJewD!I;U I5$q$ Rd1 0/RM~wT7,4U@rI9i)Z4CCP*yKeKT82. 3607 0 obj <>stream startxref LIST OF COMMON HAZARDOUS DRUGS (HDS) This Appendix is taken verbatim from the NIOSH List of and Other Hazardous Drugs in Healthcare Settings, 2016, DHHS (NIOSH) Publication No. 141 0 obj <>stream on 0000085163 00000 n All information these cookies collect is aggregated and therefore anonymous. The OFR/GPO partnership is committed to presenting accurate and reliable Workers can be protected from exposures to hazardous drugs through engineering and administrative controls, and proper protective equipment. Cookies used to make website functionality more relevant to you. CDC twenty four seven. Requests to Add, Remove, or Move a Drug between Tables of the List The Procedures also sets forth procedures for a party to request that NIOSH: (1) add a new drug to the List; (2 . Qh+Q0' PUNGF)AEx8I$d,TDI "s}Rp$u}!ZIV;I@ A$! Director, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention. Stakeholder Comments . 1503 & 1507. In fact, published studies have shown that workplace exposures to hazardous drugs can cause both acute and chronic health effects such as skin rashes, adverse reproductive outcomes (including infertility, spontaneous abortions, and congenital malformations), and possibly leukemia and other cancers. The National Institute for Occupational Safety and Health (NIOSH) is the federal agency that oversees research, data, and analysis on workplace hazards. aa_[}-:rq I(Ni!\sX |`?30~gWvl$oYtKR&^8>qxerms#"ccNq. 3566 0 obj <> endobj A Notice by the Centers for Disease Control and Prevention on 06/19/2020. January 10th, 2019 If you need to go back and make any changes, you can always do so by going to our Privacy Policy page. To view the notice and related materials, visit http://www.regulations.govexternal icon and enter CDC-2020-0046 in the search field and click Search.. 0000006330 00000 n When these documents are finalized they will be published to the NIOSH website. This list is not all-inclusive and represents an assessment of some, but not all, marketed drugs at a fixed point in time. Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. 2016-161 (Supersedes 2014-138). Centers for Disease Control and Prevention. You can review and change the way we collect information below. NIOSH requests public comment on the updated draft of the NIOSH List of Hazardous Drugs in Healthcare Settings, 2020, as well as the draft NIOSH Procedures for Developing the NIOSH List of Hazardous Drugs in Healthcare Settings, and the draft Managing Hazardous Drugs Exposures: Information for Healthcare Settings. The health risk depends on how much exposure a worker has to these drugs and how toxic they are. Defining Hazardous Drugs Hazardous drugs include those used for cancer che - motherapy, antiviral drugs, hormones, some bio-engineered drugs, and other miscellaneous drugs. An additional 18 drugs were included from the updated NIH Hazardous Drug List. (List), and (3) Managing Hazardous Drug Exposures: Information for Healthcare Settings. Academic and Professional Credentials: I.H. It is not an official legal edition of the Federal i8U While NIOSH defines criteria and identifies hazardous drugs, USP developed standards for handling these hazardous drugs to minimize the risk to public health. Organizational Affiliation: Occupational and Environmental Health Sciences %%EOF Clarification about hazardous drugs. Recommended by: Scientific or professional association, Debora Van der Sluis <<64B9B5CCA72D9D43827396971D79AAF9>]/Prev 916310>> Saving Lives, Protecting People, The National Institute for Occupational Safety and Health (NIOSH). Academic and Professional Credentials: BSN, RN Areas of Expertise, Discipline, or Relevant Experience: Occupational health 0000051059 00000 n Group 1 is antineoplastic drugs (roughly, chemotherapy . B. This repetition of headings to form internal navigation links %PDF-1.5 % Written comments, identified by CDC-2020-0046 and docket number NIOSH-233-C, may be submitted by any of the following methods: Persons with disabilities experiencing problems accessing this page should contact CDC-INFO at CDC-INFO email form: http://www.cdc.gov/info/, 800-232-4636 or the TTY number at (888) 232-6348 and ask for a 508 Accommodation PR#9342. documents in the last year, by the Indian Affairs Bureau While every effort has been made to ensure that ET on July 30, 2020. daily Federal Register on FederalRegister.gov will remain an unofficial CDC twenty four seven. Pfizer Global Environment, Health, and Safety, PhRMA Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data. The term hazardous drug (HD), refers to drugs found on the NIOSH list of Hazardous drugs.These drugs are listed due to being carcinogenic and/or for causing other toxic effects on humans. Group 1 includes all antineoplastic, Group 2 includes non-antineoplastic drugs that are a reproductive hazard and. 0000051958 00000 n The reviewers will be requested to take part in the following process: The reviewers will be required to sign a conflict of interest form and to provide their individual reviews to NIOSH. Additional information for the 2016 update can be found at: Federal Register Noticepdf icon. You can review and change the way we collect information below. Thank you for taking the time to confirm your preferences. Cookies used to make website functionality more relevant to you. If emailing please type 508 Accommodation PR#9342 without quotes in the subject line of the email. Register (ACFR) issues a regulation granting it official legal status. "Antineoplastic drugs are no longer all cytotoxic, genotoxic, and highly hazardous chemicals." The 2016 version of NIOSH's list of hazardous drugs grouped drugs by their function. 0000085885 00000 n These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. X}ic|Y\jm(5CEZf< This prototype edition of the Since its inception, it has been revised to keep up to date with drug development and evolution, and it is undergoing its most recent update. Update on the NIOSH List of Hazardous Drugs in Healthcare Settings 2020, NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2016, Closed System Drug-Transfer Device Research, Centers for Disease Control and Prevention. More information and documentation can be found in our Federal Register issue. Drugs that primarily pose a reproductive risk to men and women who are actively trying to conceive and women who are pregnant or breastfeeding Acronyms CSTD = closed system drug-transfer device PPE = personal protective equipment Citation NIOSH [2016]. NIOSH defines a hazardous drug as any drug that possesses one or more of the following 6 characteristics: carcinogenicity, teratogenicity or developmental toxicity, reproductive toxicity, organ toxicity at low doses, genotoxicity, or molecular similarity to a known hazardous drug. Document page views are updated periodically throughout the day and are cumulative counts for this document. 0000068481 00000 n March 23, 2022 If you need to go back and make any changes, you can always do so by going to our Privacy Policy page. 0000069979 00000 n In Appendix A of the Alert, NIOSH identified a sample list of major hazardous drugs. Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website. Biotechnology Industry Organization To view the notice and related materials, visit http://www.regulations.govexternal icon and enter CDC-2020-0046 in the search field and click Search., Comments will be accepted until 11:59 p.m. Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website. Until the ACFR grants it official status, the XML Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website. 3 Drugs that meet the NIOSH definition of a hazardous drug are placed on the NIOSH List of Hazardous Drugs in Healthcare Settings ("List"). Counts are subject to sampling, reprocessing and revision (up or down) throughout the day. on NARA's archives.gov. the material on FederalRegister.gov is accurately displayed, consistent with Areas of Expertise, Discipline, or Relevant Experience: Nursing https://www.federalregister.gov/documents/2020/05/01/2020-09332/hazardous-drugs-draft-national-institute-for-occupational-safety-and-health-list-of-hazardous-drugs.

Landican Cemetery Plan, Narrowboat Waste Tank,